Stockreport

Exosome Diagnostics Market to Surge: Projected Growth from USD 59M to USD 2,347M by 2029 | MarketsandMarkets™ [Yahoo! Finance]

Bio-Techne Corp  (TECH) 
Last bio-techne corp earnings: 4/30 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investors.bio-techne.com
PDF from USD 59 million in 2024 to USD 2,347 million by 2029, reflecting a compound annual growth rate (CAGR) of 108.9%. However, the launch of exosome-based therapeutics is [Read more]